Allergy Relieving Eye Drops Market - Growth, Trends, and Forecasts (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||921869|
|出版日期||內容資訊||英文 111 Pages
|全球過敏症狀緩和用眼科用藥市場:成長，趨勢，及預測(2020年∼2025年) Allergy Relieving Eye Drops Market - Growth, Trends, and Forecasts (2020 - 2025)|
|出版日期: 2020年06月01日||內容資訊: 英文 111 Pages||
The rise in prevalence and incidence rates of eye-related disorders, increased geriatric population, and increasing research and development in eye allergy medication are expected to boost the allergy-relieving eye drops market during the forecast period.
Eye Allergy has been increasing in recent years. According to a report by BioMed Research International 2017, the overall prevalence of ocular allergy among school children in Shanghai, China is about 28%. Also, it has been observed that around 15% to 20%of the US population suffers from an ocular allergy. This high prevalence of ocular allergy has increased the demand for allergy eye drops and hence, this factor has acted as a driving factor helping this market grow. However, side effects from allergy relieving eye drops, including irritation, headache, and others, have been restraining the overall growth of this market.
Antihistamines are Expected to Register a High Growth Rate Over the Forecast Period
Antihistamines are found to block histamine release from histamine-1 receptors and are used to treat the symptoms of an allergic reaction such as edema (swelling), itch, inflammation (redness), and watery eyes. Eye edema is a very common occurrence that is primarily caused by unhealthy cornea prior to surgery.
Subsequently, any procedure within the eye (such as cataract, glaucoma, or retinal surgery) can cause the cornea to fail and develop edema. Therefore antihistamines effectively treat edema and the market is expected to increase over the forecast period.
North America is Expected to Dominate the Allergy Relieving Eye Drops Market
North America includes the United States (US), Canada, and Mexico. The United States and Canada have developed healthcare systems and also spend huge amounts in research and development fo the same. Therefore, as a result, most of the global treatments are available in this region.
According to a Yanqing Feng et al, published in BioMed Research International 2017, among the US households, 34% prevalence of Ocular Allergy symptoms were reported in children. This high prevalence has thus increased the demands for ocular allergy medications, which is helping the growth of the Allergy Relieving Eye Drops market in the US region. Moreover, North America is anticipated to be a highly attractive market for allergy-relieving eye drops, owing to the high cost of prescription drugs and a significant number of people in this region covered by medical insurance.
The majority of the allergy relieving eye drops are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market growth.